July 18, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical…
Denver, Colorado, July 19, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market matures and moves into its next phase of…
New York City, NY, July 18, 2025 (GLOBE NEWSWIRE) -- The world of cryptocurrency has entered a new era—one where…
Chicago, Illinois, July 18, 2025 (GLOBE NEWSWIRE) -- Ripple (XRP) has broken through its historical price high, triggering a market…
Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has…
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on…
Patient insights informed the development of pilavapadin, Lexicon’s investigational, novel, non-opioid treatment for people suffering from DPNP July 18, 2025…
HONG KONG, July 18, 2025 (GLOBE NEWSWIRE) -- SoulGen, a leading artificial intelligence company specializing in image to video AI…
LONDON and AMSTERDAM, July 18, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing…
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Frequency Holdings Inc. (OTC: YCRM), a Nevada public company, issues this clarification following…